Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Growing health costs in Asia

Mercer’s Rose Kwan and Heena Sethi explain how employers can better manage their healthcare benefits.

Health costs in Asia continue to increase, exacerbated by an aging population, negative lifestyle changes and legislative influence on health – all of which are prompting organisations to consider less conventional methods of developing an employee benefits strategy.

A recent Mercer survey on medical trends reveals that medical costs in 40 countries across the world are set to increase by an average of 9.8% in 2016. In Asia, medical inflation is projected to increase by 11.5% in 2016, outpacing both general price inflation in the region and the global medical inflation average.

Countries expected to have the most alarming medical inflation rates this year include Vietnam at 19.3%, Malaysia at 17.3% and Indonesia at 11.8%. Drilling down further, a varying distribution of inpatient versus outpatient medical inflation becomes apparent. For example, increasing rates in Malaysia are driven primarily by outpatient costs, which account for 18.1% of total costs; in Vietnam, inpatient costs are more prevalent at 22.1%. Such disparity invites employers to take a deeper look at what is driving their own increasing costs.

An increase in non-communicable diseases is the most prominent driver of employee medical costs in Asia, owing to harmful lifestyle habits, an aging workforce, and the cost of medical technology that enables employees to live longer and therefore remain in the workforce longer.

Additional contributors to cost increase in Asia include expanded employee demands, rising incidence of chronic conditions (such as cancer and circulatory system and respiratory diseases) and the increasing prevalence of infectious diseases.

Surprisingly, inpatient claims costs for cancer and gastrointestinal diseases are trending higher than circulatory system diseases in Asia, whereas outpatient claims costs for respiratory conditions outnumber all other conditions. Factors such as increased air pollution and an increase in infectious respiratory diseases, such as tuberculosis, are likely behind the rising number of claims submitted by employees.

In addition, changes in government health care regulations are playing a part in the issue. New legislation from Vietnam’s ministry of health, for example, is expected to increase charges for patients in public hospitals, driving costs up by 30%.

Employers have traditionally focused on conventional solutions when planning and managing their employee benefits programs. Such solutions include “squeezing” insurers for the best price, or reducing the plan design and co-insurance approaches. Although these tactics do provide some relief from increasing medical costs, the results are short-term and reactionary resolutions, and in the case of reducing the coverage level, there will be a negative reaction from employees.

Rather than focusing on temporary, quick-fix remedies, employers should consider shifting toward a more holistic and integrated approach to employee benefits. Developing a more evidence-based approach that leverages both traditional methods and modern advancements in employee benefits is the way of the future.

Data analytics: employers can gauge the health of their employees by analysing claims data, but this offers a single lens and is a retrospective view. A better plan is to look at other data to identify risks and anticipate future claims costs. Drawing on correlations between different components of the medical program, such as employee risk profile and reasons for absenteeism, can help employers understand employee health behaviours before they become too costly. The key is to leverage data already collected and track other metrics to further enhance the data set.

Preventive programmes: employee benefits efforts should include programs that educate employees about how their lifestyle choices have a direct impact on their health. By taking a proactive approach that addresses both biomedical risk factors (like high blood pressure) and behavioural risk factors (such as lack of exercise), employers have a better shot at maintaining and even improving employee health.

Vendor management: increases and changes in providers’ fees account for a large part of increased medical costs, with inpatient and hospital fees being the highest contributors. Employers can evaluate their medical network strategy to understand key cost-drivers from providers, and then implement measures to monitor and manage the costs of services and products.

Employee education: responsibility versus entitlement. Employees have a role when it comes to shopping smartly, making informed choices, and managing medical costs. Employers need to educate their employees on the value of the programme, employees’ role in using the programme wisely, and that the programme is there to protect them from financial loss at the time of medical need.

Total well-being: Stress in the workplace is also key cost-driver. Employers need to avoid thinking of wellness as purely physical and consider their employees’ financial, emotional and mental well-being – communicating a more inclusive definition of wellness.

Overall, the survey revealed that governments across Asia are not providing sufficient health care systems to meet the growing diversity of patient needs, shifting much of the cost burden to the patient. To maintain and even reduce medical costs, employers should work closely with providers to develop more comprehensive benefits strategies that emphasise the importance of total well-being.

Rose Kwan is partner and Asia market business leader for employee health & benefits for Mercer, and Heena Sethi is associate director for employee health and benefits, regional consulting in APAC, for Mercer.

This piece first appeared in BRINK Asia.

Posted on: 11/08/2017 UTC+08:00


News

Lilly Asia Ventures, which makes venture capital investments in Asia for global pharmaceutical giant Eli Lilly and Company, has closed LAV Biosciences Fund IV, its fourth fund. It took only two months to reach the hard cap of US$450 million.
Summerset Group, New Zealand’s third-largest listed retirement village operator, has posted a 78% jump in profits for the first half of the year of NZ$90.3 million (US$65.9 million).
Q&M Dental Group, which operates the largest network of private dental outlets in Singapore, has reported a decline in profits for the second quarter of the year, though these are the result of the deconsolidation of two subsidiaries.
Hong Kong-listed Common Splendor International Health Industry Group is currently juggling with two acquisitions in China.
IVD and medical imaging company Yestar Healthcare has said that it is in the preliminary stage of possibly acquiring medical device companies in the northern region of China.
Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, has agreed to acquire Medtek for A$649,000 (US$512,759) shares and cash. The company provides biomedical engineering services and preventative maintenance to the medical, scientific, aged care and allied health clients in the Far North Queensland region.
Hospital operation and management group the Hospital Corporation of China (HCC) plans to buy a 70% stake in an unnamed traditional Chinese medicine private hospital in Zhejiang.
For the first half of the year private specialist healthcare provider Singapore Medical Group (SMG) has reported a massive jump in profits on the back of its move into diagnostics and aesthetics.



Analysis

Mercer’s Catherine Li explains how companies in China can avoid common pitfalls when they establish employee health management programmes.
Lieven Jacquemyn, PPP international development director at GE Healthcare Singapore, discusses how governments, providers and investors can work together to bring universal health coverage to the region.
Mercer’s Rose Kwan and Heena Sethi explain how employers can better manage their healthcare benefits.
Susann Roth, senior social development specialist, Asian Development Bank, looks at financing mechanisms to meet the third Sustainable Development Goal.
On the back of an ageing population, strong employment growth and the flow of private investment, medical and health care property will emerge as a major asset class in Western Australian’s commercial property markets according to new analysis by independent West Australian commercial property information and research firm, Y Research.
In the second part of our two-part series, Bart Van den Mooter, CEO of the TforG Group, and Helgert van Raamt, vp partnerships and new business at TforG Group, look at the medtech opportunities in China.
In part one of a two-part series, Bart Van den Mooter, CEO of the TforG Group, and Helgert van Raamt, vp partnerships and new business at TforG Group, look at the impact of reforms on medtech in China.
In what is starting to resemble a comedy of errors, Wenzhou Kangning Hospital, the largest private psychiatric specialty care service provider in China, is having to start work yet again for its A-share offering.


Civica

HealthInvestor Asia Summit

AON

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices